Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Building A High-Quality IND From Scratch With Strategic Gap Analysis
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
On-Demand Service Models Improve Clinical Trials
As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.
Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
Phase 1 Trial In Painful Diabetic Peripheral Neuropathy
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.

The Stakeholder Impact of Centralized Trial Services
5/21/2026

Real‑world experiences show how centralizing logistics and payments streamlines coordination, reduces site burden, and improves trial execution.
Go From Three Meetings To One With AI-Enabled eCOA
5/5/2026

Learn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.
Setting A New Client Standard In Study Closeout Timelines
4/4/2025

Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
The Role Of Company Culture In FSP Partnerships
8/1/2025

This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.
Oncology Clinical Trials Key Considerations: Planning For Success
10/18/2024

Chief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.

Flow Cytometry And PBMC Isolation — Powerful Tools For Your Clinical Trials

Did you know? Altasciences’ clinical facilities are integrated with state-of-the-art flow cytometry laboratories. With our deep expertise in regulated cellular analysis, our team ensures that every step — from sample collection and processing to transport and analysis — is optimized for precision and speed.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
Helping To Bring Hematologic Oncology Therapies To Cancer Patients

Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.
Rave TSDV - Improve CRA Efficiency And Reduce Site Burden

Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.
Gene Therapy Ready Site Network

Join more than 1,000 research sites who use Advarra as their IBC of record. Is your research site ready to take advantage of this growing area of clinical trials?